Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Difelikefalin on CKD-Associated Pruritus in Patients on Maintenance Hemodialysis
NCT07526324Not yet recruiting
- Sponsor
- Chattogram Medical College
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Modality
- Peptides, Small Molecules
01
Overview
Randomised, double-blind trial in chronic kidney disease (CKD) comparing Difelikefalin Group with Placebo (Normal Saline) Group (2 arms). Primary endpoint: Worst Itching Intensity Numerical Rating Scale at 6 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
difelikefalin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07526324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07526324.